By use of the autophosphorylated epidermal-growth-factor receptor and the synthetic peptide RRLIE-DAEY(P)AARG, representing an autophosphorylation site of the transforming protein of Rous-sarcoma virus, it is demonstrated that the phosphotyrosyl phosphatase activity of the polycation-stimulated phosphatases is substantially increased by an enzyme-directed effect of ATP or PP,. Concomitant with this increase in phosphotyrosyl phosphatase activity, the phosphorylase phosphatase activity is decreased, thus dramatically changing the substrate specificity of these enzymes. The dephosphorylation of four different phosphotyrosyl sites of the epidermal-growth-factor receptor is neither consecutive nor at random, but a preferred dephosphorylation of the P1 site over the P3 > P2 > P4 sites is observed. This phosphatase activity represents a substantial fraction of the total phosphotyrosyl phosphatase activity in the post-mitochondrial supernatant of Xenopus laevis oocytes.
INTRODUCTION
A role for the phosphorylation of proteins on tyrosine residues in the control of cell proliferation is implicated by the observations that protein tyrosine kinase activities are intrinsic to a number of growth-factor receptors [1] [2] [3] [4] [5] and that they are also subverted in the generation of a number of oncogenes [6] [7] [8] . The importance of these activities in the signalling role played by these individual proteins is evident from studies demonstrating that abolition of kinase activity through site-directed mutagenesis abolishes the signalling/transforming capabilities [9] [10] [11] . In the model systems that have been used to elucidate the control of cellular functions by phosphorylation, it has become increasingly clear that the role played by protein phosphatases is far from a passive one, and that complex regulatory mechanisms exist to affect steady-state protein phosphorylation through alterations in protein phosphatase activity [12] [13] [14] . Although a number of phosphotyrosyl phosphatase activities have been described (see [15] for references), there has been as yet no evidence that these activities can be regulated in an acute fashion.
Recently the PCSL (subunits 35 and 62 kDa) phosphoseryl/threonyl phosphatase from Xenopus laevis oocytes was isolated in high yield through a procedure involving tyrosine-agarose chromatography at an early point in the purification scheme. It was observed that a major p-nitrophenyl phosphatase activity co-purified with this phosphorylase phosphatase activity [16] . It has been known for some time that p-nitrophenyl phosphatase [17, 18] and low phosphotyrosyl phosphatase activities [19, 20] are associated with this type of enzyme, and highly variable but so far unexplained p-nitrophenyl phosphate/phosphorylase phosphatase activity ratios have been reported [21, 22] . The p-nitrophenyl phosphatase activity is specifically inactivated during purification, but can be restored by incubation with ATP, its analogues or PPi [16] .
During incubation with these effectors the enzyme loses its phosphorylase phosphatase activity [16] [17] [18] , thus dramatically changing the specificity of the preparation by converting the phosphoseryl phosphatase activity into a phosphophenyl phosphatase activity [16] . We 
MATERIALS AND METHODS
The PCS H9 PCSM, PCSL and PCS, phosphatases were purified from rabbit skeletal muscle [23, 24] , and the PCSL phosphatase was also purified from Xenopus laevis oocytes [16] . The active catalytic subunit of the ATP Mg2+-dependent phosphatase was purified from dog liver [25] . Calcineurin purified from bovine brain [26] Radiolabelled phosphorylase a was prepared as previously described [29] . Autophosphorylated EGF receptor was prepared by incubating 375 ,g of A431 cell membranes (preincubated at room temperature for 20 min with 1 /tM-EGF) with 20 mM-Hepes/NaOH buffer, pH 7. ture at room temperature for 1 h in the absence of ATP, the phosphorylation was initiated by the addition of ATP and continued for 16 h at 30 'C. The reaction was stopped with an equal volume of I M-acetic acid, centrifuged to remove any denatured protein, and the supernatant applied to an anion-exchange column (Bio-Rad AG-1X2; 1.5 cm x 47 cm) that had been equilibrated in 0.5 M-acetic acid. The phosphopeptide was eluted with 1 M-acetic acid while unutilized ATP remained bound to the column. Peak fractions of phosphopeptide were dried by vacuum centrifugation, resuspended in water and pooled. To separate phospho-and dephospho-peptides, the pool was applied to a 1.0 ml column of antiphosphotyrosine monoclonal antibody 1G2 (Oncogene Science, Long Island, NY, U.S.A.) conjugated to Sepharose 4B that had been equilibrated in 50 mMammonium acetate buffer, pH 6.8. The column was washed in equilibration buffer and the phosphopeptide was eluted with 0.5 M-ammonium acetate buffer, pH 6.8.
Eluted fractions containing peak amounts of radioactivity and low (0.002 maximum) to undetectable absorbance at 280 nm were dried by vacuum centrifugation, redissolved in 50 1l of water and combined, and bovine serum albumin was added to a concentration of 1 mg/ml. Phosphopeptide concentration was calculated on the basis of the specific radioactivity of the ATP in the phosphorylation reaction (only one tyrosine residue is present in the peptide substrate).
Phosphorylase phosphatase was assayed [23] with 1 mg of phosphorylase/ml. pNPP phosphatase was measured, after a preincubation with or without 2 mM-ATP, in an incubation mixture containing 20 mM-pNPP and 20 mM-MgCl2 [16] . Dephosphorylation of the src peptide was measured after a 10 min preincubation at 30°C of the phosphatase in 20 mM-Tris/HCl buffer, pH 7.5, containing 0.5 mM-dithiothreitol and 1 mg of bovine serum albumin/ml in the presence or in the absence of 1 mM-ATP or 50 /aM-PP, (as indicated in the Results and discussion section). The preincubation was stopped by diluting the mixture 5-fold with 20 mM-Tris/ HCI buffer, pH 7.5, containing 5 mM-MgCl2, 0.5 mmdithiothreitol and 1 mg of bovine serum albumin/ml. The diluted enzyme (5,u) was included in a 50,l reaction volume that routinely contained 0.3-0.4 /M-phospho-src, 0.5 mM-dithiothreitol, 1 mg of bovine serum albumin/ml and 50 mM-MgCl2 in 50 mM-Tris/HCl buffer, pH 8.6, or 2 mM-MnCl2 in 50 mM-Tris/HCl buffer, pH 7.5. The enzyme concentration in each reaction was adjusted (3-6 pg/ml) so that reaction rates remained linear for 5-10 min at 30°C and substrate depletion never exceeded 3000. Different parameters in the standard assay were varied as indicated in the Results and discussion section. The phosphatase reaction was stopped by the addition of 0.5 ml of 500 (w/v) trichloroacetic acid in 0.1 Mpotassium phosphate. Released [32P]P1 was separated as described previously [30] by passing each stopped reaction mixture over a 0.5 ml column of cation-exchange resin (Bio-Rad AG-SOW X8), which was then rinsed twice with 1.0 ml ofwater. Eluent was collected in a scintillation vial for counting of radioactivity. Dephosphorylation of the EGF receptor was carried out at 30°C in a reaction mixture containing 12 ,g of preincubated and diluted PCSL phosphatase/ml (as described above), 8-12 nMphosphorylated receptor, 20 mM-MgCl2, 50 mM-Tris/ HCI buffer, pH 8.6, 0.5 mM-dithiothreitol and 1 mg of bovine serum albumin/ml. Samples of the reaction were removed at various times and added to a 5-fold excess of 100% (w/v) trichloroacetic acid. Stopped reactions were placed on ice for 15 min and centrifuged at 10000 g. Free [32P]Pi in the supernatent was quantified by liquidscintillation counting. For analysis of the dephosphorylation of individual residues in the receptor, the pellets were redissolved in 1 M-NaOH, neutralized with 1 MTris/HCI buffer, pH 8.0, and 1 M-HCI, and diluted to 0.5 ml with water. Then 100 ,g of trypsin [L-tosylphenylalanylchloromethane-('TPCK '-) treated; Cooper Biomedical) was added and the mixtures were incubated for 24 h at 37 'C. Non-trypsin-digested protein was precipitated with trichloroacetic acid and pelleted at 10000 g, and the supernatant was applied to a Brownlee RP 300 column (2.1 mm x 100 mm) connected to a Hewlett-Packard 1090 h.p.l.c. system. Bound material was eluted with a 0-5000 (v/v) acetonitrile gradient in 0.08 % (v/v) trifluoroacetic acid [31] , and the fractions containing phosphopeptide (identified by Cerenkov scin-tillation counting) were subjected to phospho amino acid analysis.
RESULTS AND DISCUSSION
Preliminary experiments indicated that the phosphotyrosyl peptide RR-src was indeed a substrate for the PCSL phosphatase. Since this peptide substrate is readily available, it was used to characterize the phosphotyrosyl phosphatase activity in preference to the autophosphorylated EGF receptor, which is also a substrate for the PCSL phosphatase (see below). The low stoichiometry of peptide phosphorylation (less than 5 %) and an observed product inhibition of phosphatase activity by the unphosphorylated peptide (see below) necessitated separation of the phosphorylated and nonphosphorylated peptides before experimental use of the substrate. This was achieved by using an anti-phosphotyrosine monoclonal antibody covalently linked to Sepharose. Non-phosphorylated peptide was not retained by the column whereas phosphorylated peptide was retained and then eluted from the column (see the Materials and methods section).
The purified PCSL phosphatase from rabbit muscle or Xenopus oocytes displays a basal activity towards the purified phospho-src peptide. As previously observed for the p-nitrophenyl phosphatase activity [16] , this phosphotyrosyl phosphatase activity could be stimulated 3-5-fold ( (Fig. 2) , indicating that their effect is at the enzyme level and not substrate-directed. Maximum activation can be observed following incubation in the presence of 2 Mg2+ is present in the preincubation mixture (Fig. 1 mg without significantly modifying the Km of 6.9 #M (Fig. 3) . The different effectors influence the phosphotyrosyl phosphatase and p-nitrophenyl phosphatase activities of the PCSL phosphatase in a remarkably similar way. This is probably related to the mechanism of catalysis and the similarity of the substrates. However, the kinetic parameters differ largely (Km 4 mm for pNPP [16] compared with 6.9 /tM for the phosphopeptide; Vmax 53 ,umol/min per mg for pNPP [16] compared with 35 nmol/min per mg for the phosphopeptide), indicating that the integration of the phenyl phosphate into a peptide can strongly influence the affinity for the substrate and the efficiency of catalysis. After purification, the PCSL phosphatase displays phosphorylase phosphatase activity and a basal p-nitrophenyl phosphatase or src peptide phosphatase activity. Phosphorylase phosphatase activity is competitively inhibited by pNPP, indicating that the same catalytic site may be involved in the dephosphorylation of these two substrates [16] . Non-phosphorylated src peptide also inhibits phosphorylase phosphatase activity (150 = 0.5 mM). The ATP/PP1-induced activation of the phosphotyrosyl phosphatase activity of the PCSL phosphatase results in a concomitant loss of phosphorylase phosphatase activity, so that phosphorylase is no longer a substrate after preincubation with these effectors. Apparently, following the ATP/PP.-induced activation of the phosphatase the catalytic site is no longer accessible to the alkyl phosphate ofphosphorylase, whereas the phenyl phosphate moiety of phosphotyrosine or pNPP is now effectively hydrolysed. The dephosphorylation of the src peptide is inhibited by the alternative substrate pNPP (150 = 1.5 mm, measured at 0.39,tM-phosphopeptide) and by non-phosphorylated peptide (I1.5 = 0.8 mm, measured at 0.39 /,M-phosphopeptide). The latter product inhibition appears to be a common property of aryl phosphatases [32, 33] . The rather low affinity for product, as indicated by the high I50 value, does not suggest any physiological relevance. However, since all tyrosine-containing proteins could be considered potential inhibitors of phosphotyrosyl phosphatases and since there is some indication that phosphotyrosyl phosphatase inhibitors are present in the brain [34] , the observed inhibition requires further investigation.
In order to determine whether the PCSL phosphatase could dephosphorylate phosphotyrosine-containing proteins, we utilized partially purified autophosphorylated EGF receptor (3.1-3.5 mol of phosphate/mol of receptor) as a substrate. The ATP-activated PCSL phosphatase shows a specific activity of 2.4 nmol/min per mg towards this protein (present at 10 nM). The conditions of enzyme activation and requirements for phosphatase activity (metal ion, pH) are identical with those determined for the src peptide dephosphorylation (results not shown). The activated phosphatase completely removes the phosphate present exclusively on tyrosine residues (results not shown). Analysis of the time course (Figs. 4a and 4b) of dephosphorylation of the individual tyrosine residues demonstrates that removal is not strictly consecutive; it appears that the enzyme preferentially hydrolyses phosphate from the tyrosine residue 1173 of site P1 [31] , followed by the sites P3 (residue 1068) and P2 (residue 1148), and that the recently identified site P4 (J. J. Hsuan, personal communication) is the least preferred site. Although these findings show that the PCSL phosphatase can indeed dephosphorylate a tyrosinecontaining protein substrate, further studies are necessary to identify other such substrates and to determine whether or not the enzyme exhibits any degree of phosphotyrosyl phosphatase specificity akin to that evidenced by its phosphoseryl/threonyl phosphatase specificity [35, 36] .
The experiments described above were carried out with the low-Mr form of the PCS phosphatase (PCSL).
Other forms of PCS phosphatases, which differ in Mr, subunit composition, phosphoseryl/threonyl substrate specificity and activity requirements [14, 15, 35, 36] interaction results in a stable change or whether continued protein-effector interaction is required to maintain activity remains to be investigated. The ATP/PP,-activated and non-activated forms of the enzyme appear to share a common active site that specifically hydrolyses either phosphotyrosine or phosphoserine/threonine respectively. So far it has only been possible to demonstrate the conversion of a phosphoseryl phosphatase into a phosphotyrosyl phosphatase by ATP or PP1, but future studies may elucidate conditions that lead to an interconversion, an extremely interesting prospect in terms of physiological enzyme regulation. To have an idea of the cellular importance of this phenomenon in terms of relative phosphotyrosyl phosphatase activity represented by the PCS phosphatases, we measured the RR-src phosphatase activity in the post-mitochondrial supernatant of oocytes from Xenopus laevis, after separation of the different phosphatases on a DEAE-Sephacel column eluted with a 0-0.5 M-NaCl gradient. Measured under the optimal conditions for the activated phosphotyrosyl phosphatase activity (pH 8.5, plus Mg2"), the activity associated with the PCS phosphatases represents about 30°% of the total measurable phosphotyrosyl phosphatase. Therefore the conversion of serine/ threonine specificity into tyrosine specificity described above suggests a viable mode of regulation for the potentially multifunctional PCS phosphatases.
